Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C - Test2 - elhamkhani - TriplyDB

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

http://www.wikidata.org/entity/Q29619541

about

Interferon lambda: a new sword in cancer immunotherapy A new insight into hepatitis C vaccine development IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance Vaccination for hepatitis C virus: closing in on an evasive target A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection Hepatitis C virus protease inhibitor-resistance mutations: our experience and review An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?KASL clinical practice guidelines: management of hepatitis C Recent advances in understanding hepatitis C Natural killer cells in hepatitis C: Current progress Genetic background in nonalcoholic fatty liver disease: A comprehensive review NK cell function and receptor diversity in the context of HCV infection Interferon-λ: Immune Functions at Barrier Surfaces and Beyond Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection Natural history and clinical response: "it's the virus, stupid, or is it the host?"The chemokine superfamily revisited Regulation of hepatic innate immunity by hepatitis C virus Personalized medicine and human genetic diversity Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics Population genetics and human immunity: the interferon paradigm Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience Antiviral treatment of hepatitis C virus infection and factors affecting efficacy Hepatitis C virus adaptation to T-cell immune pressure Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?Immune responses to HCV and other hepatitis viruses Murine models of hepatitis C: what can we look forward to?Population genetic tools for dissecting innate immunity in humans T cell responses in hepatitis C virus infection: historical overview and goals for future research Induction and function of type I and III interferon in response to viral infection Post-transcriptional regulation of interferons and their signaling pathways Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients Genomic scale analysis of racial impact on response to IFN-alpha Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1

P2860

Q21296797-2B40B291-38C9-4AD9-928C-2814FFB2A669 Q21296858-C1D405E5-EA3E-4D62-9311-FA1753650710 Q22121973-919A06F1-7C95-4584-A811-6428856A1524 Q22305922-5E272207-B46F-48F1-B005-A548DFAD89F6 Q24307721-9F61F10A-B56D-4180-BB01-218B4C1B850F Q24611884-BFFC4B44-F282-4553-8050-7837C89073F6 Q24628717-F3049E39-69FC-48F1-9E62-D92C1EF98B5C Q24632766-4F36FFAD-8B9B-4B8E-8CD1-8C99D8E10171 Q26738545-3C8DF90C-8788-4AB2-B6FC-03F5CBB6F6AA Q26749249-0C33452F-2A24-4947-81FC-7668F5A619B5 Q26752471-E9D2E642-6D11-4346-8329-ADAF5EB17377 Q26766136-4C204373-0E65-4494-916D-40EB24FA0B11 Q26773264-BBB3E52D-26A6-4880-90CF-1C3D09563B34 Q26780248-CF637DCD-29BA-4399-B00A-3FCA90E0BADA Q26781537-1A0645F9-4A68-449E-B3A4-F35774C68267 Q26801049-8F8E7A35-142F-447C-B714-B7DDB8BC153B Q26801381-D90B6EC2-E369-4865-92E5-54EB22398922 Q26824094-071DA391-18AE-4F78-B1FF-751C8E7936A6 Q26824492-BBE8F7A2-AD72-427C-AC07-7C08D1376A5A Q26824743-CE9736FA-852A-49AB-9278-97EC6109ADB7 Q26824838-021B5BBA-8F23-4DAD-8080-90EE79F6C973 Q26825342-E186A7C1-2FE0-476A-8541-D0EB29AEB378 Q26825715-223AC56C-C2D9-434D-9102-5ABBEB01DF3E Q26827814-FD63F9BF-A31A-4EF7-A6B8-D0DE719C4852 Q26830286-C844E522-6576-43E4-844B-1632B5907E30 Q26850968-D647B04C-1153-41CD-9FF4-7CA622B5B59B Q26851810-CE339227-64A9-4394-922F-EF5C43AD495F Q26862729-86E8BCDB-7782-4EA5-817B-C97218B691C3 Q26865747-86CF80BA-48F7-4178-88EE-F4201D547D5D Q26866955-F8D2BAB6-92DD-4168-92E0-57E500E219CD Q26991875-66A2AB9E-A326-42B9-9B7F-6ECD8BF91515 Q27001032-8FC370C6-2D2A-48EF-833A-CEAE2E534090 Q27003510-AEC8E1DA-EEB1-489A-93F7-707652342234 Q27010065-BD1927F3-4748-4090-860B-C6272445C275 Q27014043-64D3B948-82F4-4140-A960-40E867D725A8 Q27014831-0704A469-C24D-4FFC-BA1B-C21CCE111DC6 Q27333253-E3BD8625-4A86-44C4-9796-A0874F0AF24C Q27490885-F3F3AD17-F904-42C5-94D6-2E9EF260248C Q27490906-BF969F90-7010-4639-A63D-45BA1FFDD55E Q27664960-27174F19-F18F-4648-8C6A-0965F3A04565

P2860

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

http://www.wikidata.org/entity/Q29619541

description

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

articolo scientifico

@it

artículu científicu espublizáu en 2009

@ast

im Oktober 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: October 2009)

@en

wetenschappelijk artikel (gepubliceerd in 2009-10)

@nl

наукова стаття, опублікована в жовтні 2009

@uk

مقالة علمية (نشرت في أكتوبر 2009)

@ar

name

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@ast

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@en

type

label

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@ast

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@en

prefLabel

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@ast

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@en

P1433

Q29619541-EA0F8864-9355-4D21-8803-EDB3198AEFA9

P1476

Q29619541-2715CC99-2D46-44E5-9847-72258C62ECAF

P2093

Q29619541-0195D71B-E4E4-4A69-8993-97413076737E

Q29619541-1063D7E5-647C-43C8-B4D6-65BA5F33F4AA

Q29619541-153A6596-EDF5-427B-A8AF-40103E29B41A

Q29619541-287B5D6A-617B-4612-A658-C649890A305B

Q29619541-33401634-4044-4CE5-A06B-5ECC175AE50A

Q29619541-36A743BF-2C81-42CF-9DE5-BC68C7E4B037

Q29619541-381C0520-F3F0-4596-ABA2-B068D66CF223

Q29619541-3D7AAC4C-CF58-4FEC-8B9C-F3D6B3EDCAC0

Q29619541-4209EB65-F783-4111-AAF8-8EDBA026BBC9

Q29619541-4BC41E98-282E-4F5D-953C-0A20137547EF

P2888

Q29619541-BC6095EB-8245-4E73-9A9E-D9879F705D92

P304

Q29619541-E723DD09-EAA1-4E18-93F6-339DF5C25948

P31

Q29619541-CB89B31C-4D81-417E-8369-647686A3EAF6

P3181

Q29619541-82E2021B-38B9-45F0-A948-2D720ACF7EF6

P356

Q29619541-B59EC03F-DFB6-44BD-895F-1D1CE351351C

P407

Q29619541-9CFF9DBE-BCF7-411C-B15A-43FECA16A4A1

P433

Q29619541-779C0A2E-51F4-4AB8-8102-5DDB75CBACAD

P478

Q29619541-241DF62A-E1E4-4504-983F-1F3AFC107C71

P577

Q29619541-7D6C1694-35C7-4D94-9227-184FBFBCDF68

P5875

Q29619541-6C40F7A3-683F-4171-AB40-25DA06A7368B

P6179

Q29619541-1E30FE52-B216-4658-A67B-59AF08F845C7

P698

Q29619541-8ADB1196-5000-4260-89AF-108086CC1410

P921

Q29619541-1A866D51-116E-40ED-879B-FEFA87E9AC00

Q29619541-33fa2191-4daf-7af7-55f6-291267a830e2

P3181

P356

P1433

Nature Genetics

P1476

Genome-wide association of IL2 ...... herapy for chronic hepatitis C

@en

P2093

Hiasa Y

http://www.w3.org/2001/XMLSchema#string

Hige S

http://www.w3.org/2001/XMLSchema#string

Hino K

http://www.w3.org/2001/XMLSchema#string

Honda M

http://www.w3.org/2001/XMLSchema#string

Imamura M

http://www.w3.org/2001/XMLSchema#string

Ito K

http://www.w3.org/2001/XMLSchema#string

Ito Y

http://www.w3.org/2001/XMLSchema#string

Izumi N

http://www.w3.org/2001/XMLSchema#string

Koike A

http://www.w3.org/2001/XMLSchema#string

Korenaga M

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1105-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

766166

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.449

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26807845

http://www.w3.org/2001/XMLSchema#string

P6179

1049900143

http://www.w3.org/2001/XMLSchema#string

P698

19749757

http://www.w3.org/2001/XMLSchema#string

P921

genome-wide association study